Five Prime Therapeutics (FPRX) Sees Windfall on Anti-CSF1R Collaboration Agreement (BMY)
Go back to Five Prime Therapeutics (FPRX) Sees Windfall on Anti-CSF1R Collaboration Agreement (BMY)| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 54.70 +0.70 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.00 | 52 Week High | $77.12 | |||
| Open | $54.20 | 52 Week Low | $49.03 | |||
| Day High | $54.73 | P/E | 35.52 | |||
| Day Low | $54.00 | EPS | $1.54 | |||
| Volume | 16,238,704 | |||||
| FIVE PRIME THER (NASDAQ: FPRX) | Delayed: 38.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.00 | 52 Week High | $57.79 | |||
| Open | $43.46 | 52 Week Low | $28.01 | |||
| Day High | $38.00 | P/E | N/A | |||
| Day Low | $38.00 | EPS | $-2.50 | |||
| Volume | 329,789 | |||||
